Results

Total Results: 1,895 records

Showing results for "drug".

121. Identification, Classification, and Frequency of Medical Errors in Outpatient Diabetes Care (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/OConnor.pdf
     November 29, 2004 - Inappropriate or risky drug prescribing occurred in 9.9 percent of the 5,729 patients. … Among the categories of drug-related medical errors are those related to drug-drug interactions, use … dl With drug intensification 159 3.8% LDL ≥ 130 mg/dl No drug intensification 536 12.9% Triglycerides … +Drug-fill date more than 4 weeks after test date. … +Type 1 lipid error is inadequate drug treatment when LDL ranges 100-129 mg/dl.

122. 003-Ss-Antimicrobial-Prophylaxis-Part-2-Fg (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-2/003-ss-antimicrobial-prophylaxis-part-2-fg.docx
     April 01, 2025 - , and discussing drug allergies. … When taking an allergy history, first ask about the drug and the reactions. … How soon after drug exposure did the reaction occur? … the patient was exposed to a drug), mechanism, and clinical presentation. … Drug allergies can be simplified into “immediate” and “delayed.”

123. ADHD Behavior Therapy References (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
     August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.

124. References (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
     August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.

125. Final Progress Report: Dissemination of the PPRNet Model for Improving Medication Safety (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/wessell-report.pdf
     January 01, 2024 - practice performance in five categories of MS: avoiding potentially inappropriate therapy, dosages, drug-drug … interactions, drug-disease interactions, and monitoring of potential adverse events. … Two drug-drug interaction indicators (ACE inhibitors or ARBs with potassium-sparing diuretics in elderly … elderly • Digoxin in the elderly with CHF • H2 blockers based on renal function Avoiding Potential Drug-Drug … and monitoring of potential adverse drug events.

126. Ncinqtobaccousehelp-References (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelp-References.pdf
     August 01, 2012 - CHIP-Program-Information/By-Topic/Early-Periodic-Screening-Diagnosis-Treatment.html National Institute on Drug … Screening for Drug Use in General Medical Settings: A Quick Reference Guide. NIH Pub No. 09-7384. … National Survey on Drug Use and Health (NSDUH). 2010 National Survey on Drug Use and Health data.

127. Final Progress Report: Improving Transplant Med Safety through a Pharmacist-Led, mHealth-Based Program (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/taber-report.pdf
     January 01, 2024 - Purpose Primary Aim • Determine the incidence, severity, and etiologies of med errors and adverse drug … Although contemporary immunosuppression is extremely effective at preventing rejection, adverse drug … Therefore, early recognition of adverse drug events in kidney transplant recipients will likely help … prescribed drug that the participant was not taking. … Ther Drug Monit. 2021 Jun 1;43(3):401-407. doi: 10.1097/FTD.0000000000000863.

128. Declines in Hospital Acquired Conditions (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/data/infographics/hac-rates-decline.pdf
     June 02, 2025 - Hospital- Acquired Conditions National efforts to reduce hospital-acquired conditions such as adverse drug … Adverse Drug Events CAUTI* *CAUTI - Catheter-Associated Urinary Tract Infections CLABSI+ Clostridium

129. Final Progress Report: Epidemiology, Exploration, and Evaluation: Addressing potentially dangerous medications in children on Medicaid with a mental health diagnosis (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/kleinman-report.pdf
     January 01, 2024 - for each year to identify the risk of Drug-Drug Interactions (DDIs) within the BMHRx members. … BMH NDC codes were rolled up to the generic drug name. … Off-Label Drug Use Study: Off-label drug use was studied each year within members with BMHRx. … (1.43, 1.48) All Cause 1.71* (1.69, 1.73) 0.92 (0.80, 1.07) 1.84* (1.80, 1.88) 2.24* (2.20, 2.28) Drug-Drug … Contraindicated drug-drug pairs are not common but occur with regularity.

130. Final Progress Report: Risk-Informed Interventions in Community Pharmacy: Implementation and Evaluation (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/cohen2-report.pdf
     January 01, 2024 - errors when taking that drug along with key clinical information about the drug. … The drug information facts were gleaned from reliable drug information resources, including the product … a professional drug information specialist and an online drug information vendor. … Drug information. … On average, staff (94%) believed that drug information updates, which include national drug code (NDC

131. Synthetic Healthcare Database for Research (SyH-DR) | Agency for Healthcare Research and Quality
     www.ahrq.gov/data/innovations/syh-dr.html
     October 01, 2024 - The database consists of a sample of inpatient, outpatient, and prescription drug claims, including utilization … 2024 (PDF, 212 KB) Primary Diagnosis Imputed Flag, January 2024 (PDF, 233 KB) Removal of Synthetic Drug

132. Final Progress Report: The Effect of EMR on Medication Safety: A SPUR-Net Study (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/kuo-report.pdf
     January 01, 2024 - including selection, dose, route of administration, frequency, and directions)  Failure to detect adverse drug-drug … , drug-disease, or drug-dietary supplement interactions at the point of care (i.e., at the prescribing … Drug Topics 2003; 6:37. 3. … Identifying drug safety issues: from research to practice. … Adverse drug events in ambulatory care.

133. Final Progress Report: Cardio-HIT Phase II (pdf file)
     www.ahrq.gov/sites/default/files/2024-12/kmetik-otoole-report.pdf
     January 01, 2024 - intolerance - 19.3%; o drug allergy - 16.2%; o drug interaction - 1.4% … intolerance – 5.7%; o drug allergy – 8.7%; o drug interaction - 0.0% … on the myalgia severity and CAD risk, or may opt for another drug from the same class. … allergy, drug interaction, and drug intolerance. … receive the drug with no reason provided.

134. 5 Tk1 T5-Sample Policy Letter Final (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK1_T5-Sample_Policy_Letter_final.docx
     October 01, 2016 - The adverse consequences of unnecessary antibiotic use include adverse drug reactions or interactions … , the development of Clostridium difficile infections, the emergence of multi-drug resistant organisms … and overuse of newer, broad-spectrum antibiotics when either no antibiotic or an older narrowspectrum drug

135. 5 Tk1 T5-Sample Policy Letter Final (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK1_T5-Sample_Policy_Letter_final.pdf
     October 01, 2016 - The adverse consequences of unnecessary antibiotic use include adverse drug reactions or interactions … , the development of Clostridium difficile infections, the emergence of multi-drug resistant organisms … overuse of newer, broad-spectrum antibiotics when either no antibiotic or an older narrow-spectrum drug

136. Recent Evidence Indicates a Flourishing Market for Biosimilar Drugs | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/943.html
     January 01, 2025 - AHRQ-supported article in Health Affairs discusses the potential of biosimilar drugs to unlock lower drug … in the decade following the Biologics Price Competition and Innovation Act of 2009, the biosimilar drug … adalimumab, the biosimilar alternative to Humira®, as a case study of the growing success of the biosimilar drug … and Evidence From AHRQ White Paper: Enhancing Systematic Review Methods by Incorporating Unpublished Drug

137. Use of Electronic Health Records | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/nhqrdr/chartbooks/carecoordination/measure5.html
     June 01, 2018 - systems that allow decision support, by component, 2012-2013 Component 2012 2013 Drug … Allergy Alerts 79 84.5 Drug-Drug Interaction Alerts 78.3 83.9 Drug-Lab Interaction … Alerts 66.6 72.7 Drug Dosing Support 62.9 71.8 Clinical Reminders 57.3 68.1 … Drug-drug interaction alerts, from 78.3% to 83.9%. … Drug-lab interaction alerts, from 66.6% to 72.7%. Drug dosing support, from 62.9% to 71.8%.

138. Implementing an Ambulatory e-Prescribing System: Strategies Employed and Lessons Learned to Minimize Unintended Consequences (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol4/Advances-Devine_83.pdf
     April 06, 2008 - - allergy and drug-drug interaction checking. … of drug-specific monitoring parameters. … The Pharmacy and Therapeutics Committee is overseeing the customization of drug-allergy and drug-drug … Similarly, the team has learned that the classification systems for drug-drug interactions used in the … The top 100 drug interactions: A guide to patient management.

139. Tk2 T4 Common Suspected Infections Tools To Improve Communication And Decisionmaking (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/nhguide/TK2_T4_Common_Suspected_Infections_Tools_To_Improve_Communication_and_Decisionmaking.docx
     October 01, 2016 - Antibiotics SAY: To return to the big picture, not only are resistant strains proliferating, but new drug … Slide 6 Developing a New Drug Is Expensive SAY: There are many reasons for the lack of development … As this slide shows, using constant dollars as its reference point, the cost of bringing a new drug to … In contrast, a new drug for a chronic problem such as high cholesterol or congestive heart failure will … Yet if antibiotic resistance does develop, it will limit the effective lifespan of the drug.

140. Number of Newborns with Neonatal Abstinence Syndrome Continued To Increase Through 2016 | Agency for Healthcare Research and Quality
     www.ahrq.gov/data/infographics/neonatal-abstinence-syndrome-2016.html
     July 01, 2019 - Text Description: The number of babies born each year with withdrawal symptoms from their mother’s drug … In 2016, more than 25,000 babies were born with withdrawal symptoms from drug dependence compared with